FDA Expands Oversight of Cell and Gene Therapies

被引：0

作者：

Wechsler, Jill

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：9 / 9

页数：1

共 50 条

[31] Report criticizes lack of FDA oversight
Mitka, Mike
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (08): : 920 - 922
[32] GAO: FDA Oversight of Produce Is Poor
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (18): : 2106 - 2107
[33] Expansion of FDA oversight power sought
不详
ISSUES IN SCIENCE AND TECHNOLOGY, 2008, 24 (02) : 17 - 18
[34] FDA BOOSTS OVERSIGHT OF IMPORTED FOOD
不详
CHEMICAL & ENGINEERING NEWS, 2013, 91 (31) : 24 - 24
[35] A Brief History of FDA Compounding Oversight
Shulman, Stanford T.
PEDIATRIC ANNALS, 2013, 42 (01):
[36] Regulatory oversight of cellular therapies
Farrugia, A.
ISBT SCIENCE SERIES, VOL 2, NO 2: STATE OF THE ART PRESENTATIONS, 2007, 2 (02): : 141 - 146
[37] FDA regulation of stem-cell-based therapies
Halme, Dina Gould
Kessler, David A.
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (16): : 1730 - 1735
[38] Autologous cell therapies: challenges in US FDA regulation
McAltister, Todd N.
Audley, David
L'Heureux, Nicolas
REGENERATIVE MEDICINE, 2012, 7 (06) : 94 - 97
[39] Social Media Engagement Post Announcement of the FDA Approval of Two Gene Therapies for Sickle Cell Disease
Thompson, Christineil
MOLECULAR THERAPY, 2024, 32 (04) : 556 - 556
[40] FDA OVERSIGHT OF CLINICAL TRIALS The US FDA and regulatory free fall
Wilson, Mark
BMJ-BRITISH MEDICAL JOURNAL, 2023, 380